The customer’s research team needed to conduct deep plasma proteomics analyses to identify novel biomarkers across multiple research projects. They were facing several obstacles:

• Limited in-house proteomics instrument availability created a months-long backlog for sample processing
• Specialized expertise was required for interpreting proteomics data
• Correlating proteomics findings with metabolomics data necessitated advanced bioinformatics capabilities not readily available internally

These challenges are not uncommon; they reflect an industry-wide trend, with biopharma companies reporting proteomics research delays due to instrumentation bottlenecks and expertise gaps or shortages. In fact, outsourcing proteomics research has become a common strategy in the life sciences industry for these very reasons.

With deadlines approaching, the customer needed a partner who could provide ongoing technological access, scientific know-how, and interpretative expertise.